The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease

Heart

Volumn 89, Issue 9, 2003, Pages 1023-1026

  Campbell, S ^a   George, D K ^b   Robb, S D ^c   Spooner, R ^a   McDonagh, T A ^d   Dargie, H J ^c   Mills, P R ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b TORBAY HOSPITAL   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENOTYPE; HEART INFARCTION; HEMOCHROMATOSIS; HUMAN; IRON STORAGE; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UNITED KINGDOM;

EID: 0042328308     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.9.1023     Document Type: Article

References (24)

1. Sullivan JL. Hypothesis: iron and the sex difference in heart disease risk. Lancet 1981;i:1293-4.
2. Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 1992;86:803-11.
3. Sempos CT, Looker AC, Gillum RF, et al. Serum ferritin and death from all causes and cardiovascular disease. The NHANES II mortality study. Ann Epidemiol 2000;10:441-8.
4. Sempos CT, Looker AC, Gillum RF, et al. Body iron stores and the risk of coronary heart disease. N Engl J Med 1994;330:1119-24.
5. Danesh J, Appleby P. Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 2001;99:852-4.
6. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
7. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
8. Anon. A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium. Gut 1997;41:841-4.
9. Miedzybrodzka Z, Loughlin S, Baty D, et al. Haemochromatosis mutations in North-East Scotland. Br J Haematol 1999;106:385-7.
10. Beutler E, Felitti V, Gelbart T, et al. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic. Ann Intern Med 2000;133:329-37.
11. Roest M, Van der Schouw YT, de Valk B, et al. Heterozygosity for a hereditary haemochromatosis gene is associated with cardiovascular death in women. Circulation 1999;100:1268-73.
12. Tuomainen TP, Kontula K, Nyyssonen K, et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland. Circulation 1999;100:1274-9.
13. Rasmussen ML, Folsom AR, Catellier DJ, et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the atherosclerosis risk in communities (ARIC) study. Atherosclerosis 2001;154:739-46.
14. Battiloro E, Ombres D, Pascale E, et al. Haemochromatosis gene mutations and risk of coronary artery disease. Eur J Hum Genet 2000;8:389-92.
15. Hetet G, Elbaz A, Gariepy J, et al. Association studies between hameochromatosis gene mutations and the risk of cardiovascular diseases. Eur J Clin Invest 2001;31:382-8.
16. Franco RF, Zago MA, Trip MD, et al. Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease. Br J Haematol 1998;102:1172-5.
17. Byrnes V, Ryan E, Barrett S, et al. Genetic hemochromatosis, a Celtic disease: is it now time for population screening? Genet Test 2001;5:127-30.
18. Tunstall-Pedoe H, Morrison C, Woodward M, et al. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985-1991: presentation, diagnosis, treatment, and 28-day case fatality of 2991 events in men and 1551 events in women. Circulation 1996;93:1981-92.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings. Bristol: John Wright and Sons, 1982.
20. Thorstensen K, Asberg A, Kvitland M, et al. Detection of an unusual combination of mutations in the HFE gene for hemochromatosis. Genet Test 2000;4:371-6.
21. Hardy GH. Mendelian proportions in a mixed population. Science 1908;28:41-50.
22. Bland JM. An introduction to medical statistics, 2nd ed. Oxford: Oxford University Press, 1995:8,125-6.
23. Calado RT, Franco RF, Pazin-Filho A, et al. HFE gene mutations in coronary atherothrombotic disease. Braz J Med Biol Res 2000;33:301-6.
24. Nassar BA, Zayed EM, Title LM, et al. Relation of HFE gene mutations, high iron stores and early onset coronary artery disease. Can J Cardiol 1998;14:215-20.